Fuad El-Hibri, Chairman at Emergent BioSolutions Inc. (EBS), sold 46,636 shares at $64.90 ($3.0M) on 2020-02-21, disclosed to the SEC on 2020-02-24.
Open-market sale of $3.0M EBS by Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.90 | 4,751 | $308K | 10.2% |
| 2 | $64.90 | 4,751 | $308K | 10.2% |
| 3 | $64.90 | 18,567 | $1.2M | 39.8% |
| 4 | $64.90 | 18,567 | $1.2M | 39.8% |
| Total | $64.90 avg | 46,636 | $3.0M | 100% |
| Filing → |
| EBS | SELL | 2020-09-25 | $3.8M | — | Filing → |
| EBS | SELL | 2020-09-18 | $6.1M | — | Filing → |
| EBS | SELL | 2020-09-11 | $4.1M | — | Filing → |